China Securities' latest research report reveals that the A-share market has scaled new heights, with the technology and non-banking financial sectors emerging as the next frontrunners. Market sentiment remains buoyant, and the China Securities Regulatory Commission has affirmed its commitment to reinforcing the positive market trajectory and fostering a robust bull market. The profit-making potential is substantial, margin trading is brisk, and new fund issuance metrics are on an upward trajectory, signaling an accelerated influx of incremental funds into the market. Amid the synergistic impact of industrial catalysts and the prevailing bull market sentiment, the technology and non-banking financial sectors are poised to usher in a relay rally. The report maintains an optimistic stance on nascent sectors like 'New Smart Medicines' (encompassing new consumption, robotics, artificial intelligence, and innovative drugs). Within innovative drugs, investors should keep an eye on catch-up opportunities in the Shanghai Stock Exchange's Main Board and Science and Technology Innovation Board, alongside previously robust targets. In artificial intelligence, focus should be on event-driven catalysts and market diffusion trends. Meanwhile, new consumption and robotics sectors also merit consistent attention.